Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study

Critical Care Medicine

Volumn 34, Issue 3, 2006, Pages 589-597

  Sakr, Yasser ^a   Reinhart, Konrad ^b   Vincent, Jean Louis ^a   Sprung, Charles L ^c   Moreno, Rui ^d   Ranieri, V Marco ^e   De Backer, Daniel ^a   Payen, Didier ^f  

^a ERASME HOSPITAL   (Belgium)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d HOSPITAL DE SANTO ANTÓNIO DOS CAPUCHOS   (Portugal)

^e UNIVERSITY OF TURIN   (Italy)

^f HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Acute circulatory failure; Catecholamines; Intensive care; Survival; Vasoactive agents; Vasopressors

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; NORADRENALIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; DEATH; DRUG FATALITY; FEMALE; FLUID BALANCE; FOLLOW UP; HEMODYNAMICS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SHOCK;

AGED; CARDIOTONIC AGENTS; CATECHOLAMINES; DOPAMINE; EUROPE; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOREPINEPHRINE; PROSPECTIVE STUDIES; RISK FACTORS; SHOCK; SHOCK, SEPTIC; SURVIVAL RATE;

EID: 33644584325     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000201896.45809.E3     Document Type: Article

References (24)

1. Ruokonen E, Takala J, Kari A, et al: Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993; 21:1296-1303
2. De Backer D, Creteur J, Silva E, et al: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med 2003; 31:1659-1667
3. Aubier M, Murciano D, Menu Y, et al: Dopamine effects on diaphragmatic strength during acute respiratory failure in chronic obstructive pulmonary disease. Ann Intern Med 1989; 110:17-23
4. Saldias FJ, Comellas AP, Pesce L, et al: Dopamine increases lung liquid clearance during mechanical ventilation. Am J Physiol Lung Cell Mol Physiol 2002; 283:L136-L143
5. Adir Y, Azzam ZS, Lecuona E, et al: Augmentation of endogenous dopamine production increases lung liquid clearance. Am J Respir Crit Care Med 2004; 169:757-763
6. Van den Berghe G, de Zegher F, Lauwers P: Dopamine suppresses pituitary function in infants and children. Crit Care Med 1994; 22:1747-1753
7. Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-1831
8. Duranteau J, Sitbon P, Teboul JL, et al: Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999; 27:893-900
9. Le Gall J-R, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
10. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. Intensive Care Med 1996; 22:707-710
11. ACCP-SCCM Consensus Conference: Definitions of sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
12. Vincent JL, Reuse C, Kahn RJ: Effects on right ventricular function of a change from dopamine to dobutamine in critically ill patients. Crit Care Med 1988; 16:659-662
13. Hasibeder W, Germann R, Wolf HJ, et al: The effects of short-term endotoxemia and dopamine on mucosal oxygenation in the porcine jejunum. Am J Physiol 1996; 270: G667-G675
14. Ruokonen E, Takala J, Kari A: Regional blood flow and oxygen transport in patients with the low cardiac output syndrome after cardiac surgery. Crit Care Med 1993; 21:1304-1311
15. Bellomo R, Kellum JA, Wisniewski SR, et al: Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 1999; 159:1186-1192
16. Bellomo R, Chapman M, Finfer S, et al: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356:2139-2143
17. Bailey AR, Burchett KR: Effect of low-dose dopamine on serum concentrations of prolactin in critically ill patients. Br J Anaesth 1997; 78:97-99
18. Devins SS, Miller A, Herndon BL, et al: Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 1992; 20:1644-1649
19. Martin C, Viviand X, Leone M, et al: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28:2758-2765
20. Dellinger RP, Carlet JM, Masur H, et al: Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873
21. Hollenberg SM, Ahrens TS, Annane D, et al: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004; 32:1928-1948
22. Pronovost PJ, Jenckes MW, Dorman T, et al: Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA 1999; 281:1310-1317
23. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
24. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377